Skip to main content

Evidence to Improve Care

Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor

Ontario Health Technology Advisory Committee Draft Recommendation

  • The Ontario Health Technology Advisory Committee recommends publicly funding magnetic resonance-guided focused ultrasound neurosurgery for people with moderate to severe, medication-refractory essential tremor

Read the Full Ontario Health Technology Advisory Committee Draft Recommendation Report Here

Thank you for your comments.

The public feedback period for this topic has ended. All comments will be considered before a final recommendation is made and posted here. Use the tabs below to learn more about this topic and download supporting draft documents including the full assessment report. To be notified once a final recommendation is posted here, sign up for our newsletter.

Essential tremor is the most common type of movement disorder and most often affects the dominant hand. As the tremor gets worse, it can negatively impact quality of life, limiting a person’s ability to perform daily activities such as eating, writing, walking, and self-care.

The first treatment available to manage essential tremor is medication, but about 50 percent of people do not respond well to medication or are unable to tolerate the side effects. The only other available treatment is neurosurgery (brain surgery), but the standard surgical treatments available are invasive procedures that involve opening the skull.

Magnetic resonance-guided focused ultrasound (MRgFUS) neurosurgery is a new, noninvasive surgical technology for the treatment of essential tremor. Since MRgFUS neurosurgery is noninvasive, it does not have the same surgical risks as invasive procedures.

Health Quality Ontario studied the effectiveness, safety, cost-effectiveness, and budget impact of publicly funding MRgFUS neurosurgery, as well as the preferences and values of people with essential tremor with regard to treatment options.

Essential tremor is estimated to affect up to 4 percent of Canadian adults, with an increase in severity and prevalence with age.

Our assessment showed that MRgFUS neurosurgery is generally safe and effective at reducing tremor severity, improving quality of life, and helping people get back to their daily activities. MRgFUS neurosurgery may be a treatment option for people with moderate to severe essential tremor for whom medication has not worked and who are unable to undergo invasive surgery or who are unwilling to accept the risks of invasive surgery.

People with essential tremor whom we interviewed who had undergone MRgFUS neurosurgery reported positive experiences with the procedure and felt that it had improved their quality of life by substantially reducing their tremors.

The cost-effectiveness analysis shows that for people with essential tremor who cannot undergo invasive neurosurgery, MRgFUS neurosurgery represents good value for money compared with no surgery. For people who can undergo invasive neurosurgery, MRgFUS neurosurgery is one of several reasonable options. The additional cost to the province to publicly fund MRgFUS neurosurgery at the current level of 48 cases per year would be about $1 million per year for the next 5 years.

Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment (PDF)
January 2018

Use of this site, and the interpretation of the information contained here, is subject to important terms and conditions. Use of this site and information except in accordance with these terms and conditions is expressly prohibited.

Health Technology Assessment at Health Quality Ontario

As part of our core function to promote health care supported by the best available evidence, we use established scientific methods to analyze the evidence for a wide range of health interventions, including diagnostic tests, medical devices, interventional and surgical procedures, health care programs and models of care. These analyses are informed by input from a range of individuals, including patients and clinical experts. The Ontario Health Technology Advisory Committee — a committee of the Health Quality Ontario board of directors — reviews the evidence and makes recommendations about whether health care interventions should be publicly funded or not. Draft recommendations are posted on the Health Quality Ontario website for feedback. Final recommendations are approved by our board of directors and then shared with the Ministry of Health and Long-Term Care. For more detailed information, visit our Evidence to Improve Care pages.


Sign up for our newsletter to receive monthly notifications of when draft recommendations are open for feedback

A senior couple looking at their tablet together

Let’s make our health system healthier

Join Our Patient, Family and Public Advisors Program

Patients, families and the public are central to improving health quality.

Claude Lurette and Kowsiya Vijayartnam, Health Quality Ontario Patient, Family and Caregiver Advisors Council Co-Chairs

Sign up for our newsletter

Are you passionate about quality health care for all Ontarians? Stay in-the-know about our newest programs, reports and news.

Health Quality Connect - Health Quality Ontario's newsletter - on an iPad and a cell phone